Clinical Trials Directory

Trials / Completed

CompletedNCT00348868

Buprenorphine HIV Care Integration Project

Miami Buprenorphine HIV Care Integration Project

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
University of Miami · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A007 is a randomized, two-arm study evaluating the effectiveness of standard drug addiction counseling with buprenorphine/naloxone to enhanced motivational drug counseling with buprenorphine/naloxone for the treatment for opioid addiction in an integrated and nonintegrated HIV care setting.

Detailed description

DESIGN: A007 is a randomized, two-arm study evaluating the effectiveness of standard drug addiction counseling with buprenorphine/naloxone to enhanced motivational drug counseling with buprenorphine/naloxone for the treatment for opioid addiction in an integrated and nonintegrated HIV care setting. DURATION: Subjects will participate in this study for approximately 48 weeks. Chart abstractions will continue for up to four years. SAMPLE SIZE: This study will enroll 60 subjects (30 per arm) over 72 weeks. POPULATION: HIV-1 infected opioid dependent men and women ≥18 years of age who initiate buprenorphine for the treatment of opioid dependence and who are receiving primary care for HIV-1 infection. STRATIFICATION: Subjects will be stratified at screening based on HIV care setting (integrated HIV care vs. nonintegrated HIV care) INTERVENTON At entry subjects will be randomized to one of the following: ARM A: Standard drug addiction counseling + buprenorphine / naloxone ARM B: Enhanced behavioral motivation counseling + buprenorphine / naloxone The three primary outcomes are: 1. Cessation of illicit opioid use 2. Reduction in high risk behavior 3. Improved HIV therapy adherence

Conditions

Interventions

TypeNameDescription
BEHAVIORALenhanced behavioral motivation counseling
BEHAVIORALMotivational counseling
BEHAVIORALStandard counseling

Timeline

Start date
2006-07-01
Primary completion
2007-12-01
Completion
2007-12-01
First posted
2006-07-06
Last updated
2008-03-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00348868. Inclusion in this directory is not an endorsement.